Murine CD4+ CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene

被引:51
作者
Su, L [1 ]
Creusot, RJ [1 ]
Gallo, EM [1 ]
Chan, SM [1 ]
Utz, PJ [1 ]
Fathman, CG [1 ]
Ermann, J [1 ]
机构
[1] Stanford Univ, Sch Med, Ctr Clin Sci, Div Immunol & Rheumatol,Dept Med, Stanford, CA 94305 USA
关键词
D O I
10.4049/jimmunol.173.8.4994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T cells (T-reg) acquire unique immunosuppressive properties while maintaining an anergy phenotype when activated in vitro under conditions that induce IL-2 production and proliferation in conventional CD4(+) T cells. We investigated the mechanism underlying one component of this naturally anergic phenotype, the inability of the T-reg cells to produce IL-2 following activation. Analysis of freshly isolated murine CD4(+)CD25(+) T-reg and conventional CD4(+)CD25(-) T cells following PMA/ ionomycin stimulation demonstrated no differences in inducible AP-1 formation, an important transcriptional complex in regulating IL-2 gene expression. Although p38 MAPK and ERK1/2 protein kinases were phosphorylated with similar kinetics, we observed diminished activation of JNK in the CD4(+)CD25(+) T-reg cells. However, lentiviral-mediated reconstitution of the JNK pathway using a constitutively active construct did not overcome the block in IL-2 synthesis. Using a PCR-based chromatin accessibility assay we found that the minimal IL-2 promoter region of CD4(+)CD25(+) T-reg cells, unlike conventional CD4 T cells, did not undergo chromatin remodeling following stimulation, suggesting that the inability of CD4(+)CD25(+) T-reg cells to secrete IL-2 following activation is controlled at the chromatin level.
引用
收藏
页码:4994 / 5001
页数:8
相关论文
共 26 条
[1]   Lentivirally transduced dendritic cells as a tool for cancer immunotherapy [J].
Breckpot, K ;
Dullaers, M ;
Bonehill, A ;
Van Meirvenne, S ;
Heirman, C ;
De Greef, C ;
van der Bruggen, P ;
Thielemans, K .
JOURNAL OF GENE MEDICINE, 2003, 5 (08) :654-667
[2]   Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process [J].
Bruniquel, D ;
Schwartz, RH .
NATURE IMMUNOLOGY, 2003, 4 (03) :235-240
[3]  
CHAN SM, 2004, IN PRESS NAT IMMUNOL
[4]   Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways [J].
DeSilva, DR ;
Feeser, WS ;
Tancula, EJ ;
Scherle, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2017-2023
[5]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[6]   Defective T cell differentiation in the absence of Jnk1 [J].
Dong, C ;
Yang, DD ;
Wysk, M ;
Whitmarsh, AJ ;
Davis, RJ ;
Flavell, RA .
SCIENCE, 1998, 282 (5396) :2092-2095
[7]   CD4+CD25+ T cells facilitate the induction of T cell anergy [J].
Ermann, J ;
Szanya, V ;
Ford, GS ;
Paragas, V ;
Fathman, CG ;
Lejon, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4271-4275
[8]   Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399
[9]   ANTIGEN PRESENTATION BY CHEMICALLY MODIFIED SPLENOCYTES INDUCES ANTIGEN-SPECIFIC T-CELL UNRESPONSIVENESS INVITRO AND INVIVO [J].
JENKINS, MK ;
SCHWARTZ, RH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) :302-319
[10]   TRANSACTIVATION BY AP-1 IS A MOLECULAR TARGET OF T-CELL CLONAL ANERGY [J].
KANG, SM ;
BEVERLY, B ;
TRAN, AC ;
BRORSON, K ;
SCHWARTZ, RH ;
LENARDO, MJ .
SCIENCE, 1992, 257 (5073) :1134-1138